Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

029IC - Testosterone Therapy: Challenges & Controversies for the Experienced Clinician (traducido en español)

Saturday, May 19
10:00 AM - 12:00 PM
Location: MCC WEST, 2002

This course will introduce and review new concepts and areas of controversy in the exciting and rapidly evolving field of testosterone therapy. The goal is to provide the attendee with a forward-looking and practical approach to diagnosis and management of the testosterone-deficient man. Topics to be addressed include: who is a candidate for T therapy; how to choose between multiple treatment options; T therapy in men with prostate cancer; the Saturation Model; effect of testosterone on general health issues, including glycemic control, metabolic syndrome, obesity, longevity; role of bone density assessment; monitoring of men on T therapy; discussion of real and alleged risks, including cardiovascular risk and sleep apnea. The material would include:

-The debate on terminology (testosterone therapy vs TRT, testosterone deficiency vs late-onset hypogonadism, etc) -Impact of testosterone therapy on obesity and metabolic conditions -In-depth review of cardiovascular data, including possibility for cardiovascular benefits -In-depth review of data regarding prostate cancer and LUTS -Use of testosterone therapy in men with a history of prostate cancer -Data regarding use of testosterone therapy in men with other conditions, including inflammatory bowel disease

In addition, we will include a section of challenging clinical cases/scenarios, such as the use of testosterone therapy in men with elevated PSA after negative biopsy, and management of complications from treatment.

Learning Objectives:

Abraham Morgentaler

Harvard Medical School

Dr. Morgentaler is a pioneer in men's health, founding the first comprehensive men's health center in the US in 1999. His research in testosterone dates to 1978, and over the ensuing 40 years his research and clinical experience has transformed the field, particularly his research regarding testosterone and prostate cancer. Dr. Morgentaler has published more than 175 scientific articles in leading medical journals, including The New England Journal of Medicine, the Journal of the American Medical Association, The Lancet, and Cancer. He is an Associate Clinical Professor of Urology at Harvard Medical School. For more than 15 years Dr. Morgentaler has co-chaired the popular forum at the annual meeting of the AUA called Clinical Controversies in Men's Health. He has lectured in more than 25 countries. Dr. Morgentaler has authored four books for the public, including The Viagra Myth, Testosterone For Life, and most recently, The Truth About Men and Sex. This past year Dr. Morgentaler helped create and served as first President of The Androgen Society (, an international, multidisciplinary professional society dedicated to the study of testosterone deficiency and its treatment. Dr. Morgentaler continues to see patients at Men's Health Boston (, operate, and perform research.


Send Email for Abraham Morgentaler

Abdulmaged M. Traish

Boston University School of Medicine


Send Email for Abdulmaged Traish


029IC - Testosterone Therapy: Challenges & Controversies for the Experienced Clinician (traducido en español)


Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Testosterone Therapy: Challenges & Controversies for the Experienced Clinician (traducido en español)